- Home
- PGHL vs AQST Comparison
PGHL vs AQST Comparison
Compare PGHL & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- AQST
- Stock Information
- Founded
- PGHL 2018
- AQST 2004
- Country
- PGHL Hong Kong
- AQST United States
- Employees
- PGHL N/A
- AQST N/A
- Industry
- PGHL
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- AQST Health Care
- Exchange
- PGHL NYSE
- AQST Nasdaq
- Market Cap
- PGHL 12.3M
- AQST 254.1M
- IPO Year
- PGHL 2024
- AQST 2018
- Fundamental
- Price
- PGHL $0.45
- AQST $2.76
- Analyst Decision
- PGHL
- AQST Strong Buy
- Analyst Count
- PGHL 0
- AQST 5
- Target Price
- PGHL N/A
- AQST $11.40
- AVG Volume (30 Days)
- PGHL 154.0K
- AQST 984.2K
- Earning Date
- PGHL 05-21-2025
- AQST 05-12-2025
- Dividend Yield
- PGHL N/A
- AQST N/A
- EPS Growth
- PGHL N/A
- AQST N/A
- EPS
- PGHL N/A
- AQST N/A
- Revenue
- PGHL $17,166,534.00
- AQST $57,561,000.00
- Revenue This Year
- PGHL N/A
- AQST N/A
- Revenue Next Year
- PGHL N/A
- AQST $39.51
- P/E Ratio
- PGHL $13.97
- AQST N/A
- Revenue Growth
- PGHL 56.11
- AQST 13.79
- 52 Week Low
- PGHL $0.37
- AQST $2.20
- 52 Week High
- PGHL $107.36
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- AQST 48.51
- Support Level
- PGHL N/A
- AQST $2.65
- Resistance Level
- PGHL N/A
- AQST $3.05
- Average True Range (ATR)
- PGHL 0.00
- AQST 0.16
- MACD
- PGHL 0.00
- AQST 0.00
- Stochastic Oscillator
- PGHL 0.00
- AQST 50.51
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.